Integrated Continuous Glucose Monitoring System, Factory Calibrated
The Integrated Continuous Glucose Monitoring System, Factory Calibrated (iCGM) is an automatic glucose monitoring device intended to measure glucose in bodily fluids continuously or frequently, designed to reliably and securely transmit glucose data to digitally connected devices including automated insulin dosing (closed-loop) systems, for use alone or in conjunction with these devices in managing glycemic control. It is classified as a Class 2 device under regulation 862.1355, requiring 510(k) premarket notification, and falls within the Clinical Chemistry (CH) medical specialty. The product code is QBJ. It is not an implant and is not life-sustaining.
Research product code QBJ in seconds
The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.
Free to try · every answer cites its records
Basic Information
- Product Code
- QBJ
- Device Class
- FDA class 2
- Regulation Number
- 862.1355
- Medical Specialty
- Clinical Chemistry
- Review Panel
- CH
- Submission Type
- 1
Device Characteristics
Definition
An integrated continuous glucose monitoring system (iCGM) is intended to automatically measure glucose in bodily fluids continuously or frequently for a specified period of time. iCGM systems are designed to reliably and securely transmit glucose measurement data to digitally connected devices, including automated insulin dosing systems, and are intended to be used alone or in conjunction with these digitally connected medical devices for the purpose of managing a disease or condition related to glycemic control.
510(k) Clearance History
Related 510(k) Clearances
This FDA classification is associated with 18 510(k) clearances via K numbers.
| K Number | Device Name | Decision Date | Decision | Applicant |
|---|---|---|---|---|
| K261402 | Dexcom G7 Continuous Glucose Monitoring System;Dexcom G7 15 Day Continuous Glucose Monitoring System | Jun 08, 2026 | Substantially Equivalent | Dexcom, Inc. |
| K253737 | Dexcom G7 Continuous Glucose Monitoring (CGM) System; Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System | Feb 03, 2026 | Substantially Equivalent | Dexcom, Inc. |
| K253710 | Dexcom G7 Continuous Glucose Monitoring (CGM) System, Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System | Dec 17, 2025 | Substantially Equivalent | Dexcom, Inc. |
| K243214 | Dexcom G7 15 Day Continuous Glucose Monitoring System | Apr 09, 2025 | Substantially Equivalent | Dexcom, Inc. |
| K240902 | Dexcom G7 Continuous Glucose Monitoring System | Apr 23, 2024 | Substantially Equivalent | Dexcom, Inc. |
| K233537 | FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System | Apr 23, 2024 | Substantially Equivalent | Abbott Diabetes Care, Inc. |
| K234133 | Dexcom G7 Continuous Glucose Monitoring System | Feb 26, 2024 | Substantially Equivalent | Dexcom, Inc. |
| K231081 | Dexcom G7 Continuous Glucose Monitoring (CGM) System | May 15, 2023 | Substantially Equivalent | Dexcom, Inc. |
| K223435 | FreeStyle Libre 3 Continuous Glucose Monitoring System; FreeStyle Libre 2 Flash Glucose Monitoring System | Apr 13, 2023 | Substantially Equivalent | Abbott Diabetes Care, Inc. |
| K222447 | FreeStyle Libre 2 Flash Glucose Monitoring System; Freestyle Libre 3 Continuous Glucose Monitoring System | Mar 03, 2023 | Substantially Equivalent | Abbott Diabetes Care, Inc. |
| K223931 | Dexcom G6 Continuous Glucose Monitoring (CGM) System | Jan 11, 2023 | Substantially Equivalent | Dexcom, Inc. |
| K213919 | Dexcom G7 Continuous Glucose Monitoring System | Dec 07, 2022 | Substantially Equivalent | Dexcom, Inc. |
| K221259 | Dexcom G6 Continuous Glucose Monitoring (CGM) System, Dexcom G6 Glucose Program Continuous Glucose Monitoring (CGM) System, Dexcom G6 Professional Continuous Glucose Monitoring (CGM) System | Jul 29, 2022 | Substantially Equivalent | Dexcom, Inc. |
| K201328 | Dexcom G6 Continuous Glucose Monitoring (CGM) System | Jul 15, 2021 | Substantially Equivalent | Dexcom, Inc. |
| K200876 | Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program Continuous Glucose Monitoring System | Dec 04, 2020 | Substantially Equivalent | Dexcom, Inc. |
| K191450 | Dexcom G6 Continuous Glucose Monitoring System, Dexcom G6 Glucose Program Continuous Glucose Monitoring System and Dexcom Pro Q Continuous Glucose Monitoring System | Jun 28, 2019 | Substantially Equivalent | Dexcom, Inc. |
| K183206 | Dexcom G6 Continuous Glucose Monitoring System | Feb 14, 2019 | Substantially Equivalent | Dexcom, Inc. |
| DEN170088 | Dexcom G6 Continuous Glucose Monitoring System | Mar 27, 2018 | Unknown | Dexcom, Inc. |
FEI Numbers
This FDA classification entry is associated with 31 FEI numbers. Click on an entry to view related FDA registrations.
Registration Numbers
This FDA classification entry is associated with 31 registration numbers. Click on an entry to view related FDA registrations.